Using iPS technology researchers develop new therapies for Parkinson's disease and ALS

Dresden. Dr. Jared Sterneckert is entering the research area " Neurodegenerative Diseases " of the DFG Research Center and Cluster of Excellence at the TU Dresden as a new junior group leader.

http://ift.tt/1pHAHSq